These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10923696)

  • 61. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models.
    Mosher LJ; Godar SC; Nelson M; Fowler SC; Pinna G; Bortolato M
    Sci Rep; 2017 Jun; 7(1):3348. PubMed ID: 28611376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Behavioral and genotoxic evaluation of rosmarinic and caffeic acid in acute seizure models induced by pentylenetetrazole and pilocarpine in mice.
    Coelho VR; Vieira CG; de Souza LP; da Silva LL; Pflüger P; Regner GG; Papke DK; Picada JN; Pereira P
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1195-1203. PubMed ID: 27476160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A revised Racine's scale for PTZ-induced seizures in rats.
    Lüttjohann A; Fabene PF; van Luijtelaar G
    Physiol Behav; 2009 Dec; 98(5):579-86. PubMed ID: 19772866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Spontaneous cure of limbic system epilepsy in the cat.
    Crowell RM; Wyss FE; Fankhauser H; Akert K
    Epilepsia; 1968 Dec; 9(4):291-301. PubMed ID: 4892446
    [No Abstract]   [Full Text] [Related]  

  • 67. "Interneurons and principal cell firing in human limbic areas at focal seizure onset".
    Weiss SA; Staba R; Bragin A; Moxon K; Sperling M; Avoli M; Engel J
    Neurobiol Dis; 2019 Apr; 124():183-188. PubMed ID: 30471414
    [No Abstract]   [Full Text] [Related]  

  • 68. Going viral: modeling limbic infection and seizure susceptibility.
    Kelly KM
    Epilepsy Curr; 2011 May; 11(3):94-5. PubMed ID: 21852873
    [No Abstract]   [Full Text] [Related]  

  • 69. Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives.
    Karthik S; Sharma LP; Narayanaswamy JC
    Neuropsychiatr Dis Treat; 2020; 16():1003-1013. PubMed ID: 32368062
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aripiprazole Selectively Reduces Motor Tics in a Young Animal Model for Tourette's Syndrome and Comorbid Attention Deficit and Hyperactivity Disorder.
    Rizzo F; Nespoli E; Abaei A; Bar-Gad I; Deelchand DK; Fegert J; Rasche V; Hengerer B; Boeckers TM
    Front Neurol; 2018; 9():59. PubMed ID: 29487562
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Behavioral fragmentation in the D1CT-7 mouse model of Tourette's syndrome.
    Santangelo A; Bortolato M; Mosher LJ; Crescimanno G; Di Giovanni G; Cassioli E; Ricca V; Casarrubea M
    CNS Neurosci Ther; 2018 Aug; 24(8):703-711. PubMed ID: 29314714
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models.
    Nespoli E; Rizzo F; Boeckers TM; Hengerer B; Ludolph AG
    Front Neurosci; 2016; 10():133. PubMed ID: 27092043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels.
    Amitai N; Weber M; Swerdlow NR; Sharp RF; Breier MR; Halberstadt AL; Young JW
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1139-49. PubMed ID: 23010529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.
    Pittenger C; Bloch MH; Williams K
    Pharmacol Ther; 2011 Dec; 132(3):314-32. PubMed ID: 21963369
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neurobiology of tourette syndrome: current status and need for further investigation.
    Felling RJ; Singer HS
    J Neurosci; 2011 Aug; 31(35):12387-95. PubMed ID: 21880899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.
    Wang L; Simpson HB; Dulawa SC
    Behav Pharmacol; 2009 Mar; 20(2):119-33. PubMed ID: 19339874
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neurosurgical strategies for Gilles de la Tourette's syndrome.
    Mukhida K; Bishop M; Hong M; Mendez I
    Neuropsychiatr Dis Treat; 2008 Dec; 4(6):1111-28. PubMed ID: 19337454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction.
    Campbell KM; Veldman MB; McGrath MJ; Burton FH
    Neuroreport; 2000 Jul; 11(10):2335-8. PubMed ID: 10923696
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.
    McGrath MJ; Campbell KM; Parks CR; Burton FH
    Brain Res; 2000 Sep; 877(1):23-30. PubMed ID: 10980239
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.